The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


ELLAONE



Laboratoire HRA PharmaEU/1/09/552/003

Main Information

Trade NameELLAONE
Active SubstancesULIPRISTAL ACETATE
Dosage FormFilm-coated tablet
Licence HolderLaboratoire HRA Pharma
Licence NumberEU/1/09/552/003

Group Information

ATC CodeG03AD02 ulipristal

Status

License statusAuthorised
Licence Issued10/11/2017
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back